← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2012Last known activity
Jan 1, 2022
Timeline
2000s
- Jun 1, 2005
Capricor Inc.— Founded
2010s
- Nov 20, 2013
Nile Therapeutics— Acquired
Drugs by trial phase (3 distinct, 16 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (0 own, 2 via acquisition)
Indications
Studied for
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Genetic Diseases, Inborn
- Genetic Diseases, X-Linked
- Heart Failure
- Infarction
- Muscular Diseases
- Muscular Disorders, Atrophic
- Muscular Dystrophies
- Muscular Dystrophy, Duchenne
- Myocardial Infarction
- Nervous System Diseases
- Neuromuscular Diseases
- Renal Insufficiency
- Ventricular Dysfunction
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (17)
- NCT04338347Lead sponsorN/A—
- NCT05126758Lead sponsorPhase 3Jan 1, 2022
- NCT04623671Lead sponsorPhase 2Nov 15, 2020
- NCT04428476Lead sponsorPhase 2Jul 31, 2020
- NCT06304064OfficialPhase 2Jun 21, 2018
- NCT06304064Lead sponsorPhase 2Jun 21, 2018
- NCT03406780Study directorPhase 2Apr 4, 2018
- NCT03406780Lead sponsorPhase 2Apr 4, 2018
- NCT02603614Study directorPhase 1/Phase 2Dec 1, 2015
- NCT02603614Lead sponsorPhase 1/Phase 2Dec 1, 2015
- NCT02485938Lead sponsorPhase 1/Phase 2Aug 1, 2015
- NCT02485938Study directorPhase 1/Phase 2Aug 1, 2015
- NCT02359227Lead sponsorPhase 2Jan 1, 2015
- NCT02293603Study directorPhase 1Nov 1, 2014
- NCT02293603Lead sponsorPhase 1Nov 1, 2014
Details
- Founded
- Beverly Hills, CA, US Jun 1, 2005
- Last known activity
- Jan 1, 2022